| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | -0.039 | 0.8 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | 0.039 | 0.8 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.0072 | 0.8 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | 0.036 | 0.8 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.0071 | 0.8 |